MedPath

EPIPAGE2 Cohort Study Follow up at Five and a Half Years

Completed
Conditions
Very Preterm Birth
Registration Number
NCT03078439
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Brief Summary

Epipage 2 (epidemiologic study on small-for-gestational-age children) is a nationwide study implemented to improve our knowledge of the outcome of preterm children in France. This study was launched on March 28, 2011 and includes three groups of preterm children, all born before 35 weeks: extremely preterm infants (born between 22 and 26 completed weeks of gestation), very preterm children (born between 27 and 31 completed weeks) and moderately preterm children (born between 32 and 34 completed weeks).

These children are being studied from their birth up to the age of 12 years. At birth, data on maternal and infants' characteristics were collected from medical records. At one and two years, questionnaires sent to families and to physicians (at two years only) allowed to collect data about the children's life and health.

At five and a half years, medical and psychological assessments are specifically implemented for the study in order to evaluate motor and cognitive disorders in this population.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3404
Inclusion Criteria
  • initially included in EPIPAGE 2 cohort or complementary studies or Elfe cohort study
  • family agreement to participate to cohort follow up
  • informed consent form signed by both parents
  • affiliated to social security system
Exclusion Criteria
  • parental refusal
  • not affiliated to any social security system

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Health disorders assessed by medical exam5 years 5 months- 5 years 11 months

According to gestational age at birth

Motor disorders assessed by medical exam5 years 5 months- 5 years 11 months

According to gestational age at birth

Cognitive disorders assessed by psychological testing5 years 5 months- 5 years 11 months

According to gestational age at birth

Behavioural disorders by psychological testing5 years 5 months- 5 years 11 months

According to gestational age at birth

Secondary Outcome Measures
NameTimeMethod
Changes in medical practices collected by questionnaire5 years 5 months- 5 years 11 months
Set up a DNA Biobank by saliva samples collection5 years 5 months- 5 years 11 months
Changes in organization of care collected by questionnaire5 years 5 months- 5 years 11 months

Trial Locations

Locations (98)

Centre Hopsitalier d'Agen

🇫🇷

Agen, France

CAMSP Albi

🇫🇷

Albi, France

CHU Amiens

🇫🇷

Amiens, France

CHU d'Angers

🇫🇷

Angers, France

CH d'Arras

🇫🇷

Arras, France

CAMSP Auch

🇫🇷

Auch, France

CAMSP Basse-Terre

🇫🇷

Basse-Terre, France

Centre Hospitalier Côte Basque

🇫🇷

Bayonne, France

CH Beauvais

🇫🇷

Beauvais, France

CHU Jean Minjoz

🇫🇷

Besançon, France

Scroll for more (88 remaining)
Centre Hopsitalier d'Agen
🇫🇷Agen, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.